ARS Pharmaceuticals, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.02B-0.04B-0.05B0.01B
Depreciation and Depletion 0.00B0.00B0.00B0.00B0.00B
Share-based Compensation 0.00B0.00B0.01B0.01B0.01B
Gains from Investment Securities 0.00B0.00B0.01B0.01B0.02B
Non-cash Items 11.39B0.06B0.03B0.07B
Cash from Operations -0.03B-0.02B-0.04B-0.06B0.01B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.00B0.00B0.00B-0.01B-0.01B
Amortization of Deferred Charges 0.00B0.00B
Depreciation & Amortization (CF) 0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in Receivables 0.01B
Change in Inventory 0.01B
Change in Accured Expenses 0.00B0.00B-0.01B-0.00B0.02B
Other Working Capital Changes 0.00B-0.00B-0.00B-0.00B0.01B
Investing Activities
Capital Expenditures 0.00B0.00B0.00B0.00B0.00B
Change in Acquisitions & Divestments 0.18B0.26B
Cash from Investing Activities -0.00B-0.00B-0.00B-0.09B-0.11B
Financing Activities
Other financing activities 0.00B
Cash from Financing Activities 0.41B0.05B0.19B0.01B0.07B
Additional items
Change in Cash 0.38B0.04B0.15B-0.14B-0.02B
Free Cash Flow -0.03B-0.02B-0.04B-0.06B0.01B
Net Cash Flow 0.38B0.04B0.15B-0.14B-0.02B